3 clinical trials found.
-
Combined Phase 3 Double-blind Randomized Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn's Disease
The primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely active ...Phase
Interventional
TRIAL ROLE: Principal Investigator
-
A Phase 3 Randomized Double-blind Placebo- and Active-controlled Parallel-group Multicenter Protocol to Evaluate the Safety and Efficacy of Guselkumab Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Disease
Under this protocol, there are 3 separate studies: a 48-week Phase 2 dose-ranging study (ie, GALAXI 1) and 2 identical 48-week Phase 3 confirmatory studies ...Phase
Interventional
TRIAL ROLE: Sub Investigator
-
A Phase 2 Multicenter Randomized Double-blind Placebo-controlled Platform Study Evaluating the Efficacy and Safety of Interventions in Participants with Moderately to Severely Active Crohn s Disease
The primary objective is to evaluate the efficacy of JNJ-active compunds as measured by the change in the Crohn’s Disease Activity Index (CDAI) score ...Phase
Interventional
TRIAL ROLE: Sub Investigator
